Pular para o conteúdo principal
Ranking Invest

WST - West Pharmaceutical Services, Inc.

Segmento: HealthcareWest Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Análise Ranking Invest

Valor de Mercado
$ 28.41 Bi
IVR
0.17Índice proprietário de comparação relativa: 0,17.
IVR2
0.07Leitura proprietária complementar: 7%.
MLL
0.07Leitura proprietária complementar: 7%.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 2.99 Bi

Dívida Líquida

-$ 232.90 Mi

L4T

$ 564.90 Mi

MM4T

16.97%

Indicadores Básicos

ROE

18.89%

Índices de Previsibilidade

Receita Líquida

B0.03

Lucro

A0.11

Margem

A0.08

Índices de Tendência

Receita Líquida

B9.34

Lucro

D1.62

Margem

E-3.63

Índices de Endividamento

DIV/PAT

-0.08

DIV/L4T

-0.41

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.